Approvals/TGA/EVOCAIR ACCUHALER 100/50 fluticasone propionate 100 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack

Approved

STANDARD

EVOCAIR ACCUHALER 100/50 fluticasone propionate 100 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 255b152036c277f4
Product Name: EVOCAIR ACCUHALER 100/50 fluticasone propionate 100 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack
Artg Id: 208194
Artg Name: EVOCAIR ACCUHALER 100/50 fluticasone propionate 100 microgram/salmeterol (as xinafoate) 50 microgram powder for inhalation blister pack
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2014-05-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

255b152036c277f4

Type

Standard